DJIA 17,139.65 108.51 0.64%
NASDAQ 4,553.77 34.87 0.77%
S&P 500 1,999.11 14.98 0.75%
market minute promo

Celgene (NASDAQ: CELG)

92.69 3.23 (3.61%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CELG $92.69 3.61%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $89.65
Previous Close $89.46
Daily Range $89.01 - $92.77
52-Week Range $66.85 - $96.44
Market Cap $74.1B
P/E Ratio 51.71
Dividend (Yield) $0.00 (0.0%)
Volume 4,071,399
Average Daily Volume 3,752,741
Current FY EPS $3.20





Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary Rss Feed

These 7 States Have the Highest Rates of Pancreatic Cancer

Pancreatic cancer is arguably the most lethal form of the disease. Find out which seven states this disease occurs in most often, as well as what new pathways are being tested to treat this terrible disease.

3 Stocks Reiterated As A Buy: CELG, BIDU, BA

14 stocks loved by top-performing fund managers

Deutsche Bank Is Bullish On Gilead Sciences, Inc. And Other Biotech Stocks

Jim Cramer's 'Mad Money' Recap: Time to Make Room for Alibaba

3 Stocks Underperforming Today In The Drugs Industry

Celgene Looks Unstoppable

3 Companies Investing In Stem Cell Research

Medivation Eyes Blockbuster As Cancer Drug Gets An OK

Trading Guidelines for Amgen, Biogen Idec, Gilead, 3 Other Biotechs

See More CELG News...

CELG's Top Competitors

CELG $92.69 (3.61%)
Current stock: CELG
AMGN $139.46 (1.08%)
Current stock: AMGN
GILD $104.84 (3.81%)
Current stock: GILD
$0.00 (0.00%)
Current stock: